LLY vs MRK
Eli Lilly and Company · Merck & Company Inc
Relative return (rebased to 100)
Key stats
| Metric | LLY | MRK |
|---|---|---|
| Price | $1,152.93 | $146.87 |
| Market Cap | $1.09T | $362.35B |
| P/E | 52.58 | 19.85 |
| P/B | 32.04 | 8.64 |
| P/S | 16.65 | 5.57 |
| ROE | 60.9% | 43.5% |
| Net Margin | 31.7% | 28.1% |
| Gross Margin | — | — |
| Revenue Growth | 44.7% | 1.3% |
| Dividend Yield | 0.54% | 2.23% |
| EPS | $21.93 | $7.40 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.